# LEVOCARNITINE
> **ANDA217896** · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2026-07-02
## Drug
- **FDA Application Number:** ANDA217896
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOCARNITINE
- **Generic name:** LEVOCARNITINE
- **Active ingredients:** LEVOCARNITINE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2026-07-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217896)
---
*MORVS · CC0 1.0*